InvestorsHub Logo
Post# of 253152
Next 10
Followers 1
Posts 38
Boards Moderated 0
Alias Born 01/21/2014

Re: DewDiligence post# 215271

Saturday, 11/18/2017 2:10:43 AM

Saturday, November 18, 2017 2:10:43 AM

Post# of 253152
Re: RVNC /FDA ODD in cervical dystonia

Isn't it more the case here that the RVNC molecule is not the same as the other approved botulism toxins that allows it to gain ODD? Only for drugs that are "otherwise the same" must the sponsor state why it may be superior.

https://www.ecfr.gov/cgi-bin/text-idx?c=ecfr&SID=238362420de6b80c19b2a9c44b73a843&rgn=div6&view=text&node=21:5.0.1.1.6.3&idno=21


In any event, daxibotulinumtoxinA is now the fifth botulism toxin granted ODD for cervical dystonia (along with baclofen).
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.